From: Drug-drug interaction among elderly patients in Africa: a systematic review and meta-analysis
Authors | Publication year | Study design | Region | Database | Sample size | Pathology | Prevalence of DDI(%) |
---|---|---|---|---|---|---|---|
Adem et al. [35] | 2022 | RCS | Ethiopia | AGS & MAI | 384 | CVD | 90.1 |
Assefa et al. [36] | 2020 | RCS | Ethiopia | Medscape online | 168 | CVD | 86.31 |
Dagnew et al. [37] | 2022 | prospective observational | Ethiopia | Medscape online | 389 | All | 58.1 |
Teka et al. [45] | 2016 | CS | Ethiopia | Micromedex | 140 | All | 62.2 |
Teni et al. [38] | 2014 | RCS | Ethiopia | Micromedex | 392 | All | 24.9 |
Bhagavathula et al. [39] | 2021 | CS | Ethiopia | Beers criteria | 320 | All | 2.8 |
Dagnew et al. [40] | 2022 | prospective observational | Ethiopia | Medscape online | 389 | All | 30.62 |
Fadare JO et al. [41] | 2016 | RCS | Nigeria | Medscape online & Epocrates | 350 | CVDs | 47.6 |
Yusuff KB et al. [16] | 2015 | CS | Nigeria | BNF & Stockley’s | 229 | All | 65 |
Abdu N et al. [42] | 2019 | CS | Eritrea | US-FDA & WebMD | 285 | All | 71.9 |
Saka SA et al. [43] | 2021 | RCS | Nigeria | Medscape online | 201 | BPH | 55.8 |
Alssageer MA et al. [14] | 2023 | RCS | Libya | Hepler and Strand | 195 | All | 23 |
Bojuwoye AO et al. [15] | 2022 | RCS | South Africa | Medscape online & Epocrates | 250 | All | 84.8 |
Dube SO [44] | 2022 | CS | South Africa | EMGuidance interaction checker | 89 | All | 80.4 |
Saka SA et al. | 2018 | RCS | Nigeria | Beers criteria | 352 | All | 5.7 |